Cargando…
Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina
There are no data in Argentina on the response rates to first-line treatment of classical Hodgkin Lymphoma (cHL) outside clinical trials. A total of 498 patients from 7 public and private hospitals in Argentina were retrospectively examined. The median follow-up was 37.4 months (CI 95% 17.7–63.5). T...
Autores principales: | Mahuad, Carolina, Victoria, Otero, Laura, Korin, Enriqueta, Martinez, Fernando, Warley, Hernán, García Rivello, Nancy, Cristaldo, Dana, Kohan, Marta, Zerga, Gonzalo, Garate, de los Ángeles, Vicente Repáraz María, Florencia, Aizpurua, Erica, Rojas Bilbao, Susana, Cerana, Eugenia, Funes Maria, Iliana, Plaza, Cecilia, Foncuberta, Anahí, Vijnovich Baron, Santiago, Cranco, Adriana, Vitriu, Mariela, Gomez, Justina, Lavalle, Claudia, Casali, Manuela, Clavijo, Luciana, Melillo, Cecilia, Cabral Lorenzo Maria, Augusto, Miroli, Laura, Fischman, Maximiliano, Pavlove, Marcela, Miodosky, Silvana, Cugliari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358792/ https://www.ncbi.nlm.nih.gov/pubmed/35950206 http://dx.doi.org/10.1007/s44228-022-00008-4 |
Ejemplares similares
-
P013: Outcomes of first-line treatment (FL) of classical Hodgkin lymphoma (cHL) in Argentina: a real life multicenter retrospective study
por: Laura, Korin, et al.
Publicado: (2022) -
Three Years Sustained Complete Remission Achieved in a Primary Refractory ALK-Positive Anaplastic T Large Cell Lymphoma Treated with Crizotinib
por: Mahuad, Carolina Valeria, et al.
Publicado: (2016) -
P041: Low percentage of T lymphocytes in Hodgkin’s Lymphoma lymph nodes, measured by flow cytometry, is associated with inferior progression free survival regardless of negative interim pet scan status
por: Korin, Laura, et al.
Publicado: (2022) -
P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.
por: Korin, L., et al.
Publicado: (2022) -
Primary NK/T cell lymphoma nasal type of the colon
por: Mahuad, Carolina Valeria, et al.
Publicado: (2013)